Search Tag: prostate cancer treatment

2024 25 Jul

  Prostate-specific membrane antigen (PSMA)-targeted alpha therapy (TAT) has emerged as a promising treatment for advanced-stage metastatic castration-resistant prostate cancer (mCRPC). Since its introduction in 2014, PSMA-TAT has shown significant potential in controlling tumour growth. However, the treatment is not without challenges, particularly...Read more